| First Author | Du XH | Year | 2023 |
| Journal | Cell Death Dis | Volume | 14 |
| Issue | 1 | Pages | 56 |
| PubMed ID | 36693850 | Mgi Jnum | J:332806 |
| Mgi Id | MGI:7429405 | Doi | 10.1038/s41419-023-05579-5 |
| Citation | Du XH, et al. (2023) USP14 promotes colorectal cancer progression by targeting JNK for stabilization. Cell Death Dis 14(1):56 |
| abstractText | MAPK/JNK signaling is pivotal in carcinogenesis. However, ubiquitin-mediated homeostasis of JNK remains to be verified. Here, with results from RNA sequencing (RNA-seq) and luciferase reporter pathway identification, we show that USP14 orchestrates MAPK/JNK signaling and identify USP14 as a deubiquitinase that interacts and stabilizes JNK. USP14 is elevated in colorectal cancer patients and is positively associated with JNK protein and downstream gene expression. USP14 ablation reduces cancer cell proliferation in vitro and colorectal tumorigenesis in vivo by downregulating MAPK/JNK pathway activation. Moreover, USP14 expression is induced by TNF-alpha, forming a feedback loop with JNK and leading to tumor amplification. Our study suggests that elevated expression of USP14 promotes MAPK/JNK signaling by stabilizing JNK, which in turn augments colorectal carcinogenesis, indicating a potential therapeutic target for colorectal cancer patients with increased USP14 expression. |
